Lisata Therapeutics, Inc. (LON:0HS8)
London
· Delayed Price · Currency is GBP · Price in USD 2.590
+0.087 (3.48%)
At close: Feb 13, 2025
Lisata Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
25
Market Cap
16.93M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| BP p.l.c. | 149.68B |
| British American Tobacco p.l.c. | 25.87B |